HEALIUS LIMITED — Director's Dealing 2022

Feb 23, 2022

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name	of	entity	HEALIUS LIMITED
ABN			24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Robert Hubbard
Date of last notice	22 November 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [449 x 295] intentionally omitted <==

----- Start of picture text ----- Direct or indirect interest DirectNature of indirect interestN/A(including registered holder)Note: Provide details of the circumstances givingrise to the relevant interest.Date of change 23 February 202220,080 NED Share Rights Robert Hubbard21,518 Ordinary Shares* Robert Hubbard51,951 Ordinary Shares Paris SMSF ATFRobert Hubbard &No. of securities held prior toLeanne Mullerchange25,000 Ordinary Shares Hubbard Investments PtyLtd* Shares are subject to a holding lock as “Restricted Shares” under the NED Share Plan.Class Fully paid Ordinary SharesNumber acquired 10,040Number disposed N/A----- End of picture text -----

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide detailsand estimated valuation	$50,000 cash equivalent using the volume weighted averageprice of Ordinary Shares over the five business daysimmediately following the Healius Limited Annual GeneralMeeting on 21 October 2021, being $4.98.
No. of securities held afterchange	10,040 NED Share RightsRobert Hubbard31,558 Ordinary Shares*Robert Hubbard51,951 Ordinary SharesParis SMSF ATF RobertHubbard & LeanneMuller25,000 Ordinary SharesHubbard InvestmentsPty Ltd*Shares are subject to a holding lock as “Restricted Shares” underthe NED Share Plan.
Nature of changeExample:on-markettrade,off-markettrade,exercise of options, issue of securities underdividend reinvestment plan, participation in buy-back	Vesting of 50% of NED Share Rights issued in respect of FY2022 into Ordinary Shares (restricted) under the NED SharePlan.

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	Not applicable
If so, was prior written clearance provided to allow thetrade to proceed during this period?	Not applicable
If prior written clearance was provided, on what date wasthis provided?	Not applicable

Authorised by the Company Secretary.

Charles Tilley Company Secretary Date: 24 February 2022

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011